Best Penny Stocks Under 25 Cents Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. These penny stocks all have a super-low share price of $0.25 or less and are sorted by average trading volume in dollars. These companies are considered the most actively-traded stocks priced under $0.25. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. TPI Composites NASDAQ:TPIC$0.12 -0.11 (-48.51%) Closing price 08/18/2025Extended Trading$0.12 0.00 (0.00%) As of 08/18/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.TPI Composites, Inc manufactures and sells composite wind blades, and related precision molding and assembly systems to original equipment manufacturers (OEMs) in the United States, Mexico, Europe, the Middle East, Africa, and India. More about TPI CompositesMarket Capitalization$5.90 millionP/E Ratio-0.03Consensus RatingReduceConsensus Price Target$1.73 (+1,332.5% Upside)Volume69.85 million sharesAverage Volume44.66 million shares Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. Adaptimmune Therapeutics NASDAQ:ADAP$0.06 -0.01 (-14.51%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$0.06 +0.00 (+0.85%) As of 08/29/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom. More about Adaptimmune TherapeuticsMarket Capitalization$15.61 millionP/E Ratio-0.09Consensus RatingHoldConsensus Price Target$1.35 (+2,194.9% Upside)Volume40.30 million sharesAverage Volume85.34 million shares3. ESSA Pharma NASDAQ:EPIX$0.24 +0.01 (+2.13%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$0.24 0.00 (-1.25%) As of 08/29/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ESSA Pharma Inc, a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. More about ESSA PharmaMarket Capitalization$11.35 millionP/E Ratio-0.43Consensus RatingHoldConsensus Price Target$2.00 (+733.3% Upside)Volume9.77 million sharesAverage Volume16.63 million shares4. Abpro NASDAQ:ABP$0.25 +0.00 (+0.57%) As of 08/29/2025 03:59 PM EasternAbpro Holdings Inc is a biotechnology company. The company's mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. More about AbproMarket Capitalization$19.65 millionConsensus RatingBuyConsensus Price Target$4.00 (+1,532.0% Upside)Volume3.32 million sharesAverage Volume6.12 million sharesToday's Range$0.24▼$0.255. Carisma Therapeutics NASDAQ:CARM$0.22 -0.01 (-5.70%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$0.47 +0.26 (+119.53%) As of 08/29/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Carisma Therapeutics, Inc, a clinical-stage cell therapy company, focuses on discovering and developing immunotherapies to treat cancer and other serious diseases in the United States. More about Carisma TherapeuticsMarket Capitalization$8.98 millionP/E Ratio-0.14Consensus RatingModerate BuyConsensus Price Target$1.93 (+795.3% Upside)Volume69.60 million sharesAverage Volume5.02 million shares6. Heatwurx NASDAQ:PCSA$0.19 -0.02 (-10.68%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$0.18 -0.01 (-2.65%) As of 08/29/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Processa Pharmaceuticals, Inc, a clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment. More about HeatwurxMarket Capitalization$9.52 millionP/E Ratio-0.08Consensus RatingModerate BuyConsensus Price Target$2.00 (+958.2% Upside)Volume3.67 million sharesAverage Volume5.20 million shares7. Wag! Group NASDAQ:PET$0.05 -0.07 (-58.89%) Closing price 07/29/2025Extended Trading$0.05 0.00 (0.00%) As of 07/29/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Wag! Group Co develops and supports a proprietary marketplace technology platform available as a website and mobile app that enables independent pet caregivers to connect with pet parents. More about Wag! GroupMarket Capitalization$2.44 millionP/E Ratio-0.12Consensus RatingHoldConsensus Price Target$6.00 (+12,374.0% Upside)Volume28.29 million sharesAverage Volume12.53 million shares8. Windtree Therapeutics NASDAQ:WINT$0.10 0.00 (-0.94%) As of 08/29/2025 03:52 PM EasternWindtree Therapeutics, Inc, a biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. More about Windtree TherapeuticsMarket Capitalization$348 thousandP/E Ratio0.00Consensus RatingHoldConsensus Price Target$350.00 (+367,933.6% Upside)Volume233,507 sharesAverage Volume5.76 million shares9. MariMed OTCMKTS:MRMD$0.15 +0.02 (+11.92%) As of 08/29/2025 03:59 PM EasternMariMed Inc engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. More about MariMedMarket Capitalization$60.13 millionConsensus RatingStrong BuyVolume4.85 million sharesAverage Volume2.06 million sharesToday's Range$0.13▼$0.1850-Day Range$0.07▼$0.1510. bioAffinity Technologies NASDAQ:BIAF$0.24 0.00 (-1.02%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$0.24 +0.00 (+1.20%) As of 08/29/2025 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. More about bioAffinity TechnologiesMarket Capitalization$6.89 millionConsensus RatingHoldVolume169,942 sharesAverage Volume479,514 sharesToday's Range$0.24▼$0.2550-Day Range$0.23▼$0.3711. Crypto OTCMKTS:CRCW$0.0039 +0.00 (+14.71%) As of 08/29/2025 03:59 PM EasternThe Crypto Company does not have significant operations. It was previously involved in the provision of consulting and education services for distributed ledger technologies, for the building of technological infrastructure, and enterprise blockchain technology solutions. More about CryptoConsensus RatingModerate BuyVolume188.74 million sharesAverage Volume24.40 million sharesToday's Range$0.0034▼$0.006250-Day Range$0.0006▼$0.005152-Week Range$0.0005▼$0.009412. Nextech3D.AI OTCMKTS:NEXCF$0.08 +0.00 (+6.53%) As of 08/29/2025 03:56 PM EasternNextech3D.AI Corporation provides augmented reality technologies, wayfinding technologies, and 3D model services. It focuses on creating 3D WebAR photorealistic models for the prime ecommerce marketplace, as well as other online retailers. More about Nextech3D.AIMarket Capitalization$11.47 millionP/E Ratio-1.60Consensus RatingBuyConsensus Price Target$0.25 (+212.9% Upside)Volume552,653 sharesAverage Volume788,111 shares13. Ayr Wellness OTCMKTS:AYRWF$0.03 0.00 (-4.17%) As of 08/29/2025 03:49 PM EasternAyr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. More about Ayr WellnessMarket Capitalization$2.94 millionConsensus RatingModerate BuyConsensus Price Target$3.00 (+11,757.7% Upside)Volume599,579 sharesAverage Volume1.89 million sharesToday's Range$0.02▼$0.0314. Ascot Resources OTCMKTS:AOTVF$0.04 +0.00 (+7.30%) As of 08/29/2025 03:12 PM EasternAscot Resources Ltd. engages in the exploration, evaluation, and development of mineral properties in the United States and Canada. More about Ascot ResourcesConsensus RatingHoldVolume188,479 sharesAverage Volume592,511 sharesToday's Range$0.04▼$0.0450-Day Range$0.04▼$0.0652-Week Range$0.03▼$0.4115. Ontrak NASDAQ:OTRK$0.07 -0.01 (-14.82%) As of 08/29/2025 03:59 PM EasternOntrak, Inc operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States. More about OntrakMarket Capitalization$305 thousandP/E Ratio0.00Consensus RatingBuyConsensus Price Target$3.00 (+4,043.6% Upside)Volume181,335 sharesAverage Volume270,523 shares16. Vincerx Pharma NASDAQ:VINC$0.03 -0.01 (-24.94%) As of 08/29/2025 03:26 PM EasternVincerx Pharma, Inc, a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. More about Vincerx PharmaMarket Capitalization$170 thousandP/E Ratio0.00Consensus RatingBuyConsensus Price Target$40.00 (+122,976.9% Upside)Volume145,819 sharesAverage Volume556,253 shares17. Exro Technologies OTCMKTS:EXROF$0.04 0.00 (-8.48%) As of 08/29/2025 03:44 PM EasternExro Technologies Inc focuses on developing generation power-control electronics in Canada. The company offers Exro Coil Driver, which allows the motor to switch between different operational profiles in real-time, as well as have multiple gears for scooters, electric bikes, recreational, light electric cars, motorcycles, fleet vans, electric buses, passenger vehicles, long-haul trucks, and industrial vehicles markets; and Exro Cell Driver, a stationary energy storage system for commercial and industrial energy storage applications. More about Exro TechnologiesMarket Capitalization$21.02 millionConsensus RatingReduceVolume418,968 sharesAverage Volume233,690 sharesToday's Range$0.04▼$0.0450-Day Range$0.04▼$0.0618. Leafly NASDAQ:LFLY$0.20 -0.02 (-8.41%) As of 08/29/2025 03:50 PM EasternLeafly Holdings, Inc owns and operates a platform to provide consumers with cannabis information and connects consumers to cannabis brands and licensed retailers. More about LeaflyMarket Capitalization$628 thousandP/E Ratio-0.09Consensus RatingBuyConsensus Price Target$9.18 (+4,483.1% Upside)Volume8,200 sharesAverage Volume22,575 shares19. Pinstripes NYSE:PNST$0.05 0.00 (-0.57%) As of 08/29/2025 03:18 PM EasternPinstripes Holdings Inc operates a dining and entertainment concept restaurants. The company provides Italian-American food and beverage menu with bowling, bocce, and event space. More about PinstripesMarket Capitalization$2.11 millionConsensus RatingBuyConsensus Price Target$2.50 (+4,661.9% Upside)Volume5,465 sharesAverage Volume82,192 sharesToday's Range$0.05▼$0.0520. Nikola OTCMKTS:NKLAQ$0.03 0.00 (0.00%) As of 08/29/2025 03:33 PM EasternNikola Corporation operates as a technology innovator and integrator that develops energy and transportation solutions in the United States and internationally. More about NikolaMarket Capitalization$1.83 millionP/E Ratio0.00Consensus RatingHoldConsensus Price Target$6.00 (+19,900.0% Upside)Volume17,931 sharesAverage Volume100,298 shares21. SpringBig NASDAQ:SBIG$0.04 +0.00 (+6.06%) As of 08/29/2025 03:09 PM EasternSpringBig Holdings, Inc develops and operates a software platform that provides marketing and customer engagement services to cannabis dispensaries and brands in the United States and Canada. More about SpringBigMarket Capitalization$1.64 millionP/E Ratio-0.44Consensus RatingHoldVolume15,000 sharesAverage Volume72,922 sharesToday's Range$0.04▼$0.0422. Virpax Pharmaceuticals NASDAQ:VRPX$0.01 0.00 (0.00%) As of 08/29/2025Virpax Pharmaceuticals, Inc, a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. More about Virpax PharmaceuticalsMarket Capitalization$14 thousandConsensus RatingHoldAverage Volume166,969 sharesToday's Range$0.0111▼$0.011150-Day Range$0.01▼$0.4652-Week Range$0.01▼$26.2523. West China Cement OTCMKTS:WCHNF$0.23 0.00 (0.00%) As of 08/29/2025West China Cement Limited, an investment holding company, manufactures and sells cement and cement products in the People's Republic of China. More about West China CementConsensus RatingSellAverage Volume3,133 sharesToday's Range$0.23▼$0.2350-Day Range$0.18▼$0.2352-Week Range$0.12▼$0.2324. Omega Therapeutics OTCMKTS:OMGAQ$0.0030 0.00 (0.00%) As of 08/11/2025Omega Therapeutics, Inc operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by restoring aberrant gene expression to a range without altering native nucleic acid sequences. More about Omega TherapeuticsMarket Capitalization$166 thousandP/E Ratio0.00Consensus RatingModerate BuyConsensus Price Target$4.00 (+133,233.3% Upside)Average Volume215,590 sharesToday's Range$0.0030▼$0.003025. Syros Pharmaceuticals NASDAQ:SYRS$0.0020 +0.00 (+25.00%) As of 08/29/2025 02:57 PM EasternSyros Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development of treatment for hematologic malignancies. More about Syros PharmaceuticalsMarket Capitalization$1.65 millionP/E Ratio0.00Consensus RatingHoldConsensus Price Target$1.00 (+49,900.0% Upside)Volume6,428 sharesAverage Volume178,232 shares More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 08/25 - 08/29 Ollie’s Bargain Outlet: Buy it While It’s Still a Bargain Tencent Music Stock Outshines Spotify as China’s Music Giant Best Buy Marketplace: Potential Growth Catalyst or Risky Gimmick? DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy? CrowdStrike at a Crossroads: AI Halo vs. Risks Snowflake’s Snowballing Business and Robust Stock Price Outlook NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
